Literature DB >> 7693946

CFTR transcripts are undetectable in lymphocytes and respiratory epithelial cells of a CF patient homozygous for the nonsense mutation R553X.

K Will1, J Reiss, M Dean, M Schlösser, R Slomski, J Schmidtke, M Stuhrmann.   

Abstract

In order to analyse the influence of the nonsense mutation R553X on CFTR gene expression, transcripts from epithelial cells and lymphocytes were examined from nine subjects (one CF patient homozygous for R553X, one CF patient compound heterozygous for R553X/delta F508, four CF carriers heterozygous for R553X, one CF carrier with the genotype delta F508/N, and two uncharacterized normal adults). After reverse transcription of the region from exons 10 to 13 to cDNA, fragments of the expected size were amplified from all heterozygous and normal subjects. In three subjects an additional alternatively spliced product was observed, which was found to contain a termination codon. In repeated experiments it was not possible to detect any CFTR mRNA in cells derived from the R553X homozygous patient. Furthermore, in subjects heterozygous for R553X we could not detect by hybridisation with a specific oligonucleotide probe and direct sequencing any CFTR mRNA derived from the R553X allele. However, the wild type product was present in all of these subjects. Our results support the view that nonsense mutations in the CFTR gene can lead to a reduction or absence of cytoplasmic CFTR mRNA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693946      PMCID: PMC1016565          DOI: 10.1136/jmg.30.10.833

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  25 in total

1.  Genotype analysis of cystic fibrosis patients in relation to pancreatic sufficiency.

Authors:  M Stuhrmann; M Macek; A Reis; J Schmidtke; B Tümmler; T Dörk; V Vavrova; M Macek; M Krawczak
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

2.  Alternative splicing in the first nucleotide binding fold of CFTR.

Authors:  K Will; M Stuhrmann; M Dean; J Schmidtke
Journal:  Hum Mol Genet       Date:  1993-03       Impact factor: 6.150

3.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

4.  Altered regulation of airway epithelial cell chloride channels in cystic fibrosis.

Authors:  R A Frizzell; G Rechkemmer; R L Shoemaker
Journal:  Science       Date:  1986-08-01       Impact factor: 47.728

5.  Diagnosis of sickle cell anemia and beta-thalassemia with enzymatically amplified DNA and nonradioactive allele-specific oligonucleotide probes.

Authors:  R K Saiki; C A Chang; C H Levenson; T C Warren; C D Boehm; H H Kazazian; H A Erlich
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

6.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

7.  Nonsense mutation causing steroid 21-hydroxylase deficiency.

Authors:  H Globerman; M Amor; K L Parker; M I New; P C White
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

8.  Five mutant alleles of the insulin receptor gene in patients with genetic forms of insulin resistance.

Authors:  T Kadowaki; H Kadowaki; M M Rechler; M Serrano-Rios; J Roth; P Gorden; S I Taylor
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

9.  Nonsense mutations in the dihydrofolate reductase gene affect RNA processing.

Authors:  G Urlaub; P J Mitchell; C J Ciudad; L A Chasin
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

10.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

View more
  6 in total

1.  Exon skipping through the creation of a putative exonic splicing silencer as a consequence of the cystic fibrosis mutation R553X.

Authors:  Isabel Aznarez; Julian Zielenski; Johanna M Rommens; Benjamin J Blencowe; Lap-Chee Tsui
Journal:  J Med Genet       Date:  2007-05       Impact factor: 6.318

2.  Cystic fibrosis with homozygous R553X mutation in a Taiwanese child.

Authors:  Hui-Ju Chen; Shuan-Pei Lin; Hung-Chang Lee; Chih-Ping Chen; Nan-Chang Chiu; Han-Yang Hung; Schu-Rern Chern; Chih-Kuang Chuang
Journal:  J Hum Genet       Date:  2005-11-10       Impact factor: 3.172

3.  [Cystic fibrosis and associated complications].

Authors:  C Schwarz; D Staab
Journal:  Internist (Berl)       Date:  2015-03       Impact factor: 0.743

4.  Clinical features of cystic fibrosis patients with rare genotypes.

Authors:  G Castaldo; E Rippa; V Raia; D Salvatore; C Massa; G de Ritis; F Salvatore
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

5.  Microlesions and polymorphisms in the Duchenne/Becker muscular dystrophy gene.

Authors:  F Rininsland; J Reiss
Journal:  Hum Genet       Date:  1994-08       Impact factor: 4.132

6.  A novel exon in the cystic fibrosis transmembrane conductance regulator gene activated by the nonsense mutation E92X in airway epithelial cells of patients with cystic fibrosis.

Authors:  K Will; T Dörk; M Stuhrmann; T Meitinger; R Bertele-Harms; B Tümmler; J Schmidtke
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.